Navigation Links
HistoRx and Lilly Extend, Expand AQUA(R) Analysis Partnership
Date:3/26/2008

as companion diagnostics.

HistoRx currently has 10 such partnerships with leading pharmaceutical companies such as Lilly involving therapeutics in multiple stages of development. Researchers at these companies are using AQUA(R) analysis-based assays to identify correlations of biomarker expression with clinical outcomes, including drug dosing effects, therapeutic mechanism of action, drug safety, and therapeutic efficacy.

"We consider this expanded agreement with Lilly, one of the world's leading innovation-driven pharmaceutical companies, to be a tremendous validation of the HistoRx AQUA(R) technology," said Rana K. Gupta, CEO of HistoRx. "By revealing stronger, more reliable statistical correlations linking protein biomarker expression with prediction of patient response to therapy and disease outcome, we expect this ongoing partnership to continue providing a substantial boost to Lilly's drug research and development programs."

About HistoRx (http://www.historx.com)

HistoRx, Inc. is a leader in the emerging field of tissue-based diagnostic products for targeted patient treatment. The company's products and services are based on proprietary AQUA(R) technology, the first platform capable of measuring biomarker concentration with subcellular resolution in tissue sections in a fully standardized and automated manner. HistoRx partners with pharmaceutical and biotechnology companies to generate precise and cost- effective answers about the safety and effectiveness of targeted therapeutics in development for cancer and other diseases. These partnerships provide the foundation for HistoRx to develop companion diagnostic tests that will be co- marketed with partners' targeted therapeutics. HistoRx also pursues internal programs to develop proprietary diagnostics that will enable improved treatment decisions in cancer care.

CONTACT:

Mary Moynihan

M2Friend Biocommunicat
'/>"/>

SOURCE HistoRx, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Lilly Announces Termination of AIR Insulin Program
2. In response to a New England Journal of Medicine article published yesterday and subsequent media coverage, Eli Lilly and Company issued the following statement:
3. Daiichi Sankyo, Lilly Submit New Drug Application for Investigational Antiplatelet Drug, Prasugrel, with U.S. Food and Drug Administration
4. Lilly and BioMS Medical Announce Global Licensing and Development Agreement
5. Robert Conley, M.D. to Join Lilly; Will assume a neuroscience leadership role as a Distinguished Lilly Scholar
6. Lilly Declares Fourth-Quarter Dividend
7. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
8. Neptune Technologies expands into medicinal markets in Asia Pacific
9. CMPMedica Expands SearchMedica.com with Multiple Additional Vertical Search Applications co-developed with Convera(R)
10. Nova Biosource Fuels Expands Senior Executive Team
11. FDA Clears Expanded Use of Xofts Axxent(R) Electronic Brachytherapy System for all Radiation Therapy Indications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...alif., Nov. 6 Intarcia Therapeutic...TCA 650 (DUROS® continuous delivery of exenat...at the Ninth Annual Diabetes Technology Meeting in...om.com/cgi-bin/prnh/20050301/SFTU126LOGO ) ,, ... ITCA 650 Lowers Plasma Glucose, HbA1c and Reduces...
(Date:11/5/2009)..., N.J., Nov. 5 DSM Pharmaceutical ...cturing alliance with Galenix, Saint Jean D,Illac,...l scale manufacturing partner for Galenix commerci...ix will collaborate on business development opport...ogies, based on the strength of Galenix in drug pr...
(Date:11/5/2009)...N.Y., Nov. 5 BioSpecific...ceutical company developing first-in-class collage... results for the third quarter ended September 30,...ptember of this year, the FDA,s Arthritis Advisory...2-0, the approval of XIAFLEX(TM) for the treatment...
(Date:11/5/2009)...xas, Nov. 5 SpineSmith Partners ha...to co-develop a unique scaffold that mimics the st...luation of several commercial products by SpineSmi...any believes the GenOsteo scaffold represents a si... unique and ideal environment for the delivery of ...
Breaking Biology Technology:Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 2Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 3Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 4Intarcia Therapeutics, Inc. Presents Positive Results from Two Studies of ITCA 650 for the Treatment of Type 2 Diabetes at the Ninth Annual Diabetes Technology Meeting 5DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SpineSmith Partners and GenOsteo Announce Collaborative Product Development Agreement 2
... EDMONTON, Sept. 3 /PRNewswire-FirstCall/ - BioMS... treatment of multiple sclerosis (MS), announced,t...bid. Under the bid,which will be conducted pursuan..."), the Company may purchase up to 1,000,000 of it...esenting approximately 1.1% of the,Company,s issue...
.... (Nasdaq:,PLXS) announced today that it intends t...tered into an agreement to lease approximately 106...ted in Hangzhou. The new,facility will allow Plexu...ecision centers in the greater Shanghai area, and ...tal cost value proposition. This location,will be ...
...ity of Manchester who discovered the world,s thinn...work. , Professor Andre Geim FRS and Dr Kostya No...ology have been awarded the prestigious Europhysic...ubsequent work to reveal its remarkable electronic... of carbon atoms resembling chicken wire. This inc...
Other Biology Technology:BioMS Medical announces its intention to renew a normal course issuer bid 2BioMS Medical announces its intention to renew a normal course issuer bid 3Plexus Announces Expansion in Hangzhou, China 2Plexus Announces Expansion in Hangzhou, China 3Graphene pioneers follow in Nobel footsteps 2
(Date:11/3/2009)...en are as much as 28 percent less likely to become...ng to research that earned a Michigan State Univer...by Barbara Luke, a researcher in the MSU College o...ology and Reproductive Biology, focused on data of...echnology. , Luke,s findings, which also can be ...
(Date:11/3/2009)...y Samueli School of Engineering and Applied Scienc...ed in the laboratory the enzyme responsible for pr...lovastatin. , The research, published Oct. 23...to the development of other compounds with similar...esizing enzyme is one of the most interesting but ...
(Date:11/3/2009)...of Illinois at Chicago have received $1 million fr... study the relationship between "fat taxes" and fo...funding for the two-year project was made availabl...ct of 2009. , The study will link state tax rate...gar- and fat-laden foods and beverages (soda, cand...
Breaking Biology News(10 mins):MSU researcher: Obesity significantly cuts odds of successful pregnancy 2UCLA researchers reconstitute enzyme that synthesizes cholesterol drug lovastatin 2UIC receives $1 million grant to study 'fat taxes,' diet, obesity 2Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 1Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 2Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 3Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 4Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 5Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 6Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 7Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 8Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 9Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 10Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 11Neovasc Inc Reports Second Quarter 2009 Financial Results 54835 12Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 1Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 2Phytomedics Inc Announces Publication of the Phase 2b Clinical Trial Results of an Extract of the Chinese Herbal Remedy Tripterygium wilfordii Hook F 4868 3Valley Riding Will Host Horse Festival in the Cleveland Metroparks on Sunday August 23 from 11 AM to 4 PM 54833 1Valley Riding Will Host Horse Festival in the Cleveland Metroparks on Sunday August 23 from 11 AM to 4 PM 54833 2
...e about how the brain assigns cells to participate...versity of Toronto team has discovered that a prot...ing a role in memory formation. The April 20 edit... a new approach for preserving memory in people su... , "Making a memory is not a conscious act," expla...
...al nervous system (CNS) in animal evolution has pu...ts and worms evolved from the same ancestor, but t...volved only after their lineages had split during ... Biology Laboratory (EMBL) in Heidelberg now revea...uch older than expected. The study, which is publi...
...tel, cancer is a metaphorical example of the perfe...regnant finch that landed on a deserted island in ...n the human body has to undergo many mutations thr...vader of different organs in the body. But once it...fferent ecological niches, cancer is tough to get ...
Other Biology News:UCLA/Toronto researchers unlock key to memory storage in brain 2The origin of the brain lies in a worm 2New bird, bat species revealed by extensive DNA barcode studies 2
Mouse cAMP / Ca2+ Signaling PathwayFinder, PCR Array for expression profiling from SuperArray Bioscience
Rabbit Anti-EEF2K Monoclonal Antibody, Unconjugated, Clone EP881Y from Abcam
Human Regulatory T cell (Foxp3 / CD4 / CD25) Flow Cytometry staining Kit from eBioscience
Weinreb Linker from ChemPep, Inc.
Biology Products: